SSRIs Elevate Intratumoral Serotonin and Enhance Antitumor Immunity
出处
期刊:Cancer Discovery [American Association for Cancer Research] 日期:2025-01-01
标识
DOI:10.1158/2159-8290.cd-rw2025-054
摘要
Major Finding: Serotonin transporter depletes intratumoral serotonin which dampens CD8+ T-cell antitumor immunity.Concept: Serotonin transporter inhibition with SSRIs drives T-cell antitumor immunity and suppresses tumor growth.Impact: SSRIs synergize with anti-PD-1 therapies and represent a promising avenue for cancer immunotherapy.